CA
NZ
UK
AU
IND
US
Compass Diversified Holdings announced a comprehensive revision to its management fee and incentive compensation framework, slated to become effective on January 1 2027. The Ninth Management Services Agreement.1 and approved by independent directors, introduces a tiered fee schedule and cash‑based awards for the upcoming …
Faraday Future Intelligent Electric Inc. (NASDAQ: FFAIW) announced a restructuring of its capital raising plan on July 9 2026. The amendment revises the original securities purchase agreement and includes a broad warrant cancellation that will affect millions of shares.
The Federal Reserve’s decision to raise its benchmark rate is set to weigh on global equity markets, prompting a swift pullback across most indices. Analysts anticipate that the initial reaction will be negative, but long‑term patterns suggest a rebound once the policy stance is …
Investors are anticipating the company's Q2 2026 earnings release scheduled for August 6, building on Oscar's transformative Q1 turnaround. That turnaround included a record $679 million net profit, 52% revenue growth, and an improved medical loss ratio of 70.5%.
Accenture plc (NYSE: ACN) has completed a significant debt financing round, issuing senior notes across multiple maturities. Proceeds will support general corporate purposes, including potential acquisitions and operational expansion.
This discrepancy has resulted in Berkshire Hathaway trailing the S&P 500 by 12.4 percentage points, a significant gap that reflects the company's struggles in the current financial environment. The performance of Berkshire Hathaway has a substantial impact on the financial sector, given its size …
Post-earnings selling pressure continues following the company's Q2 miss last week, where EPS of -$0.81 came in below the -$0.72 consensus and revenue of $9.04 million badly missed the $15.29 million estimate. Despite the earnings disappointment, a wave of analyst price target upgrades — …
Shares are declining amid a broader semiconductor selloff as renewed U.S.-Iran hostilities rattled global markets and sent oil prices surging, weighing on chip stocks entering an already high-stakes week. A Zacks analysis published today highlights the company's strong fundamentals — a Q1 beat, a …
Company-specific sentiment remains focused on pipeline catalysts, particularly the pilavapadin Phase 3 program (SONATA) and the Novo Nordisk partnership for LX9851, which carries up to $1.0 billion in potential milestones. The stock's recent addition to the Russell 2000 and Russell 3000 indices in late …
The stock is declining amid a broad semiconductor and tech selloff, as renewed U.S.-Iran conflict sent oil prices surging and rattled risk sentiment across chip-related stocks. The weakness comes despite strong analyst backing, including Cantor Fitzgerald's $600 price target and Morgan Stanley's $442 target, …
Please wait processing your request...